HOLLY BECKER: Open Payments
NPI 1699154674 · CARLISLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$394 in 20 payments from 12 companies in 2025. Trend: 2023 $188 · 2024 $312 · 2025 $394
Food & beverage: $394
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $68 |
| Vanda Pharmaceuticals Inc. | 2 | $54 |
| Teva Pharmaceuticals USA, Inc. | 3 | $50 |
| Lilly USA, LLC | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Corcept Therapeutics | 1 | $21 |
| Lundbeck LLC | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: HETLIOZ, UBRELVY, AUSTEDO XR, AIRSUPRA, MOUNJARO, Auvelity, CAPLYTA, Korlym.
Industry payments across KY — which companies pay providers there.
